CLS launches US website focusing on TRANBERG® for MRI-guided laser ablation
Clinical Laserthermia Systems AB (publ) today launches a US version of its company website. In the US CLS’ TRANBERG®| Thermal Therapy System and single use accessories are marketed for treatment with MRI-guided laser ablation, following the FDA-clearance that the products hold. The new website will be launched sometime after 4 PM CET today and is accessed on www.clinciallaser.se as well as on www.clinicallaser.com.
Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 – (0)702 – 90 33 00 E-mail: firstname.lastname@example.org
Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and have subsidiaries in Berlin, Germany and Boston, MA,USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s website: www.clinicallaser.se